Truist Financial Increases HCA Healthcare (NYSE:HCA) Price Target to $430.00

HCA Healthcare (NYSE:HCA) had its target price boosted by investment analysts at Truist Financial from $390.00 to $430.00 in a report issued on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Truist Financial’s target price would indicate a potential upside of 14.57% from the company’s previous close.

A number of other research firms also recently issued reports on HCA. Barclays lifted their target price on HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research report on Wednesday, July 24th. UBS Group boosted their price target on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. JPMorgan Chase & Co. boosted their price target on HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a research report on Thursday, May 30th. Royal Bank of Canada boosted their price target on HCA Healthcare from $329.00 to $378.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Finally, Baird R W raised HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Four research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $354.67.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $375.31 on Monday. The firm has a market cap of $98.30 billion, a price-to-earnings ratio of 18.71, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68. The stock’s 50-day moving average is $341.89 and its 200-day moving average is $329.44. HCA Healthcare has a one year low of $215.96 and a one year high of $377.88. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The business had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $4.29 earnings per share. Equities analysts predict that HCA Healthcare will post 22.43 earnings per share for the current fiscal year.

Insider Transactions at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the completion of the transaction, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Kathleen M. Whalen sold 2,987 shares of HCA Healthcare stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the transaction, the senior vice president now owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. The disclosure for this sale can be found here. Insiders have sold 8,844 shares of company stock valued at $3,185,932 in the last 90 days. 1.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Vanguard Group Inc. raised its holdings in shares of HCA Healthcare by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock worth $5,666,569,000 after purchasing an additional 60,304 shares during the period. Sanders Capital LLC raised its holdings in shares of HCA Healthcare by 4.2% in the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after purchasing an additional 456,738 shares during the period. Wellington Management Group LLP raised its holdings in shares of HCA Healthcare by 1.7% in the 4th quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock worth $2,757,181,000 after purchasing an additional 170,560 shares during the period. Royal Bank of Canada raised its holdings in HCA Healthcare by 35.7% during the 4th quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after acquiring an additional 1,183,890 shares during the period. Finally, Capital World Investors raised its holdings in HCA Healthcare by 57.5% during the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after acquiring an additional 1,019,750 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.